Vitamin D3 Supplementation Increases Fibroblast Growth Factor-23 in HIV-Infected Youths Treated with Tenofovir Disoproxil Fumarate
Peter L. Havens(Children's Hospital of Wisconsin), Kathleen Mulligan(University of California, San Francisco), Craig M. Wilson(University of Alabama at Birmingham), Catherine M. Gordon(Eunice Kennedy Shriver National Institute of Child Health and Human Development), Alyne Baker(Tulane University), James Bethel(Westat (United States)), Charles B. Stephensen(Western Human Nutrition Research Center), Bill G. Kapogiannis(Eunice Kennedy Shriver National Institute of Child Health and Human Development), Jorge Luján‐Zilbermann(University of South Florida), Jennifer J. Kiser, Nancy Liu(Westat (United States)), Cynthia G. Pan(Children's Hospital of Wisconsin), Leslie R. Woodhouse(Agricultural Research Service), Marta D. Van Loan(University of California, Davis), Brandy Rutledge(Westat (United States)), Patricia M. Flynn(St. Jude Children's Research Hospital), Rohan Hazra
Cited by 13
Related Papers
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2009|3.6k
Maternal Viral Load, Zidovudine Treatment, and the Risk of Transmission of Human Immunodeficiency Virus Type 1 from Mother to Infant
|New England Journal of Medicine|1996|817
Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection
|Clinical Infectious Diseases|2018|728
MRP4: A previously unidentified factor in resistance to nucleoside-based antiviral drugs
|Nature Medicine|1999|580
Risk Factors for Perinatal Transmission of Human Immunodeficiency Virus Type 1 in Women Treated with Zidovudine
|New England Journal of Medicine|1999|553